iSpecimen Inc(ISPC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:44 PM ET (Korea 9/12 08:44)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -50.28 | Insider Own | - | Shs Outstand | 2.5M | Perf Week | -4.55% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 2.5M | Perf Month | -35.24% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | - | Inst Own | 2.58% | Short Float | 5.71% | Perf Quarter | -46.55% |
| Income | -0.01B | P/S | 7.88 | EPS this Y | - | Inst Trans | 382.06% | Short Ratio | 0.25 | Perf Half Y | -83.59% |
| Sales | 0.00B | P/B | 1.29 | EPS next 5Y | - | ROA | -170.1% | Short Interest | 0.14M | Perf YTD | -85.87% |
| Book/sh | 1.14 | P/C | 0.84 | EPS past 3/5Y | 53.84% 30.62% | ROE | -968.47% | 52W High | -98.58% ($103.20) | Perf Year | -97.22% |
| Cash/sh | 1.75 | P/FCF | - | Sales past 3/5Y | -42.97% -25.1% | ROIC | -596% | 52W Low | 6.52% ($1.38) | Perf 3Y | -99.73% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 86.78% | Gross Margin | -355.95% | Volatility(W/M) | 11.65% 9.87% | Perf 5Y | -99.97% |
| Dividend TTM | - | EV/Sales | -0.99 | Sales Y/Y TTM | -92.11% | Oper. Margin | -2020.04% | ATR (14) | 0.18 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.82 | EPS Q/Q | 94.17% | Profit Margin | -2449.04% | RSI (14) | 32.92 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.82 | Sales Q/Q | -78.69% | SMA20 | -15.4% ($1.74) | Beta | 1.62 | Target Price | $2400 |
| Payout | - | Debt/Eq | 0.14 | Earnings | - | SMA50 | -27.3% ($2.02) | Rel Volume | 0.3 | Prev Close | $1.5 |
| Employees | 7 | LT Debt/Eq | 0.1 | EPS/Sales Surpr. | - | SMA200 | -80.18% ($7.42) | Avg Volume(3M) | 0.58M | Price | $1.47 |
| IPO | 2021/6/17 | Option/Short | No/Yes | Trades | 1261 | Volume | 174,115 | Change | -2% |
Company
ISPC is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A U.S. micro-cap company that operates a digital marketplace connecting human biospecimens (blood, tissue, cells, and other biological samples) and clinical data with life science researchers. It maintains a network of hospitals, research institutions, and biospecimen providers, and has recently announced a Solana blockchain-based digital asset treasury strategy as well.
Over the past 1 year, on the lower side
99% below its 1-year high.
ISPC has weak earning power
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -99.7% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 2.6%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
VXF 0.00%It ranks #4 in the industry
Based on market cap of $4M.
ISPC $4M PER -
TMO $225B PER 32.8
DHR $141B PER 35.5
NTRA $47B PER -
FAQ
What kind of company is ISPC?
ISPC belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of ISPC?
The market cap of ISPC is approximately $4M, ranking 5,758 within its sector.
What is the 52-week high and low for ISPC?
ISPC has recorded a 52-week high of $103.20 and a low of $1.38.
